OTC Markets OTCQB · Biotechnology

Protagenic Therapeutics (PTIX)

Stock, pipeline and biotech catalyst intelligence

Analyst view

Not covered

Ratings unavailable

$0.80+0.20 (+33.5%)Latest market snapshot · Yahoo Finance

Market cap$1.4M

Cash$565,985

Quarterly burn$509,667

Pipeline assets1

Short float3.3%

Latest coverage

News & Press Releases

External sources

Aug 20, 2026

Protagenic Therapeutics Receives FDA Pre-IND Feedback Supporting New IND for PT00114 in Generalized Anxiety DisorderACCESS Newswire

Jun 30, 2026

Protagenic Therapeutics' Lead Candidate PT00114 Attenuated Chronic Stress Responses in a Well-Established Rodent ModelACCESS Newswire

Company profile

About Protagenic Therapeutics

Protagenic Therapeutics, Inc. operates as a pharmaceutical company specializing in the development of medicines manufactured from cannabinoid and cannabinoid-like molecules. The company was founded in 2004 and is based in New York, New York.

Company profile supplied by Yahoo Finance. Catalyst dates can change and should be confirmed against the linked primary source.

Page updated Aug 21, 2026 · Yahoo quotes cached for one minute; reference data may be used when a live field is unavailable.